Binding of BCL9 to β-catenin can also be blocked by natural compounds13,23, stapled helices mimicking HD226 or rationally-designed small molecules27, which attenuate β-catenin-dependent transcription in colorectal cancer cells and β-catenin-dependent tumourigenesis in mouse models. The gene discussed is BCL9; the disease is colorectal cancer.